GSK Investigational Site — Edmond, Oklahoma

GSK Investigational Site is a clinical research site located in Edmond, Oklahoma, United States 73013.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

GSK Investigational Site has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Influenza, Human, Pulmonary Disease, Chronic Obstructive, Systemic Lupus Erythematosus.

Sponsors: GlaxoSmithKline.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Edmond

Browse all research sites in Oklahoma · View every site in Edmond

• OK Clinical Research
• Research Site
• Retina Vitreous Center
• Tekton Research
• Clinical Investigations
• Conrad Clinical Research
• Clinical Research Site
• Summit Medical Center
• Retina Vitreous Center, PLLC
• Tekton Research- Edmond
• Retina Vitreous Center in Edmond Oklahoma

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GSK Investigational Site?

GSK Investigational Site has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GSK Investigational Site conducted?

GSK Investigational Site has 5 clinical trials on record, with 1 currently active. Their work covers Influenza, Human, Pulmonary Disease, Chronic Obstructive, Systemic Lupus Erythematosus.

Is GSK Investigational Site accredited by Crixeo Clinical Trials?

GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GSK Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.